Clofarabine

CAS No. 123318-82-1

Clofarabine ( Clolar; Evoltra )

Catalog No. M10922 CAS No. 123318-82-1

Clofarabine(Clolar; Clofarex) inhibits the enzymatic activities of ribonucleotide reductase (IC50 = 65 nM) and DNA polymerase.

Purity : >98%(HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 32 In Stock
10MG 49 In Stock
25MG 78 In Stock
50MG 122 In Stock
100MG 158 In Stock
200MG 204 In Stock
500MG 341 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Clofarabine
  • Note
    Research use only, not for human use.
  • Brief Description
    Clofarabine(Clolar; Clofarex) inhibits the enzymatic activities of ribonucleotide reductase (IC50 = 65 nM) and DNA polymerase.
  • Description
    Clofarabine(Clolar; Clofarex) inhibits the enzymatic activities of ribonucleotide reductase (IC50 = 65 nM) and DNA polymerase.
  • Synonyms
    Clolar; Evoltra
  • Pathway
    Cell Cycle/DNA Damage
  • Target
    DNA/RNA Synthesis
  • Recptor
    RR
  • Research Area
    Cancer
  • Indication
    ——

Chemical Information

  • CAS Number
    123318-82-1
  • Formula Weight
    303.68
  • Molecular Formula
    C10H11ClFN5O3
  • Purity
    >98%(HPLC)
  • Solubility
    DMSO: 60 mg/mL (197.57 mM)
  • SMILES
    O[C@H]1[C@H](CO)O[C@@H](N2C=NC3=C(N)N=C(Cl)N=C23)[C@@H]1F
  • Chemical Name
    (2S,3S,4R,5R)-5-(6-amino-2-chloro-9H-purin-9-yl)-4-fluoro-2-(hydroxymethyl)tetrahydrofuran-3-ol

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Bonate PL, et al. Nat Rev Drug Discov, 2006, 5(10), 855-863.
molnova catalog
related products
  • CX-3543

    CX-3543 (Quarfloxin, Itarnafloxin) is a small molecule nucleolus-targeting agent that selectively disrupts nucleolin/rDNA G-quadruplex complexes in the nucleolus.

  • T863

    T-863(DGAT-1 inhibitor) is an orally active, selective and potent DGAT1 (Acyl-CoA:diacylglycerol acyltransferase 1) inhibitor that interacts with the acyl-CoA binding site of DGAT1, and inhibits triacylglycerol synthesis in cells.

  • T2AA

    T2AA is an inhibitor of proliferating cell nuclear antigen (PCNA) with IC50 of 1 μM for PCNA/PIP-box peptide interaction.